John Mumm

Company: DEKA Biosciences

Job title: President & CEO

Seminars:

Therapeutically Restoring the IL-10 Circuit in Crohn’s Patients 4:00 pm

• People who lack sufficient IL-10 signalling develop Crohn’s disease • Inflammation is complex, driven by hyperinflammatory monocytes and pathogenic Th1/Th17 T cells • DK410 (VEGFR2) combines IL-10 to block monocytic inflammation and IL-4 to block Th1/Th17 polarization and enriches the cytokines in the neovasculature driven by chronic inflammationRead more

day: Pre-Conference Focus Day